JPWO2021171002A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021171002A5
JPWO2021171002A5 JP2022550778A JP2022550778A JPWO2021171002A5 JP WO2021171002 A5 JPWO2021171002 A5 JP WO2021171002A5 JP 2022550778 A JP2022550778 A JP 2022550778A JP 2022550778 A JP2022550778 A JP 2022550778A JP WO2021171002 A5 JPWO2021171002 A5 JP WO2021171002A5
Authority
JP
Japan
Prior art keywords
seq
optionally
sequence
lcdr1
lcdr2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022550778A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023516925A5 (https=
JP2023516925A (ja
Publication date
Priority claimed from GBGB2002581.3A external-priority patent/GB202002581D0/en
Application filed filed Critical
Publication of JP2023516925A publication Critical patent/JP2023516925A/ja
Publication of JP2023516925A5 publication Critical patent/JP2023516925A5/ja
Publication of JPWO2021171002A5 publication Critical patent/JPWO2021171002A5/ja
Pending legal-status Critical Current

Links

JP2022550778A 2020-02-24 2021-02-24 新規の抗体 Pending JP2023516925A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2002581.3A GB202002581D0 (en) 2020-02-24 2020-02-24 Novel antibodies
GB2002581.3 2020-02-24
PCT/GB2021/050459 WO2021171002A1 (en) 2020-02-24 2021-02-24 Novel antibodies

Publications (3)

Publication Number Publication Date
JP2023516925A JP2023516925A (ja) 2023-04-21
JP2023516925A5 JP2023516925A5 (https=) 2024-02-13
JPWO2021171002A5 true JPWO2021171002A5 (https=) 2024-02-13

Family

ID=70108379

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022550778A Pending JP2023516925A (ja) 2020-02-24 2021-02-24 新規の抗体
JP2022550813A Pending JP2023514437A (ja) 2020-02-24 2021-02-24 Ex vivoガンマデルタt細胞集団

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022550813A Pending JP2023514437A (ja) 2020-02-24 2021-02-24 Ex vivoガンマデルタt細胞集団

Country Status (17)

Country Link
US (2) US20230159638A1 (https=)
EP (3) EP4591882A3 (https=)
JP (2) JP2023516925A (https=)
KR (2) KR20220145894A (https=)
CN (2) CN115697401A (https=)
AU (2) AU2021228266A1 (https=)
BR (2) BR112022016894A2 (https=)
CA (2) CA3168973A1 (https=)
CL (1) CL2022002296A1 (https=)
CO (2) CO2022013542A2 (https=)
EC (1) ECSP22074030A (https=)
GB (1) GB202002581D0 (https=)
IL (2) IL295852A (https=)
MX (2) MX2022010383A (https=)
PE (1) PE20230438A1 (https=)
WO (2) WO2021171002A1 (https=)
ZA (1) ZA202209699B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202006989D0 (en) * 2020-05-12 2020-06-24 Gammadelta Therapeutics Ltd Methods for isolating gamma delta t cells
AU2022222299A1 (en) 2021-02-17 2023-09-07 F-Star Therapeutics Limited Multispecific anti-tcr delta variable 1 antibodies
CN119080924B (zh) * 2024-07-04 2025-02-25 上海交通大学医学院附属第九人民医院 一种单克隆免疫球蛋白及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016081518A2 (en) * 2014-11-17 2016-05-26 Adicet Bio, Inc. Engineered gamma delta t-cells
AU2016274633B2 (en) * 2015-06-09 2022-04-21 Gammadelta Therapeutics Ltd Methods for the production of TCR gamma delta+ T cells
EP3454870A4 (en) * 2016-05-12 2020-03-04 Adicet Bio Inc. METHOD FOR SELECTIVE EXPANSION OF GAMMA DELTA T CELL POPULATIONS AND COMPOSITIONS THEREOF
GB201818243D0 (en) 2018-11-08 2018-12-26 Gammadelta Therapeutics Ltd Methods for isolating and expanding cells
CA3145523A1 (en) * 2019-08-16 2021-02-25 GammaDelta Therapeutics Limited Therapeutic uses of anti-tcr delta variable 1 antibodies

Similar Documents

Publication Publication Date Title
RU2559525C2 (ru) Белки, связывающие простагландин е2, и их применение
TWI508745B (zh) TNF-α結合蛋白
JP2020520665A5 (https=)
US20050176028A1 (en) Deimmunized binding molecules to CD3
RU2020124623A (ru) Антитела, специфичные к гетеродимеру cd3-дельта/эпсилон
JP2021514973A5 (https=)
JP2018537962A5 (https=)
JP2018512170A5 (https=)
TW201124427A (en) IL-1 binding proteins
CN103145839A (zh) Il-12/p40结合蛋白
JP2021500916A5 (https=)
JP2015523962A5 (https=)
JP2025183307A5 (https=)
JP2021512652A5 (https=)
JPWO2020011973A5 (https=)
JP2026026084A5 (https=)
JPWO2021171002A5 (https=)
IL277899B2 (en) Methods and preparations for treating yellow fever
JP2021533806A5 (https=)
JP2021521201A5 (https=)
WO2022023566A2 (en) Cd-3 antibodies for the treatment of coronavirus
JPWO2020257289A5 (https=)
JPWO2022079139A5 (https=)
JPWO2021171003A5 (https=)
WO2020183471A1 (en) A method for immunosuppression